STOCK TITAN

Tarsus Pharmaceuticals, Inc. reported $451.4M in revenue and a $66.0M net loss for fiscal 2025. See the full TARS financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Tarsus to Participate in Upcoming Investor Conferences

Tarsus (NASDAQ:TARS) announced that management will attend two investor events: the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, and the H.C.

(Neutral)
(Very Positive)
Tags
conferences

Tarsus (NASDAQ:TARS) announced that management will attend two investor events: the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, and the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, which will include a fireside chat at 6:00 a.m. PT / 9:00 a.m. ET. Live webcasts, replays, and additional details will be available in the events section of the Tarsus website, with replays posted within 48 hours and archived for a limited time.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – TARS

+11.80% 3.4x vol
78 alerts
+11.80% Session close to close
+21.9% Peak in 5 hr 59 min
$3.63B Market Cap
3.4x Rel. Volume

In the Sep 2 session, TARS gained 11.80%, reflecting a significant positive market reaction. Argus tracked a peak move of +21.9% during that session. Our momentum scanner triggered 78 alerts that day, indicating high trading interest and price volatility. Trading volume was very high at 3.4x the daily average, suggesting strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences:

  • Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8th
  • H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15th, where management plans to participate in a fireside chat at 6:00 a.m. PT / 9:00 a.m. ET.

Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of ocular rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease, both of which are in Phase 2, and IRX-101 for potential use as an ocular antiseptic.

Media Contact:
Adrienne Kemp
Vice President, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com


FAQ

When will Tarsus (NASDAQ:TARS) present at the Wells Fargo 21st Annual Healthcare Conference?

Tarsus management plans to attend the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8. According to Tarsus, investors can access live webcasts and related information through the events section of the company’s website, with replays available afterward for a limited time.

What is the date and time of Tarsus (TARS) fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference?

Tarsus management will participate in a fireside chat on Tuesday, September 15 at 6:00 a.m. PT / 9:00 a.m. ET. According to Tarsus, this session will be available via live webcast on the events section of its website, with a replay posted within 48 hours.

How can investors access the Tarsus (TARS) investor conference webcasts in September 2026?

Investors can access Tarsus conference webcasts through the events section of the Tarsus website. According to Tarsus, both the Wells Fargo and H.C. Wainwright sessions will be broadcast live, with webcast links and details posted on the events page for convenient access.

Will replays be available for the Tarsus (NASDAQ:TARS) September 2026 investor conference presentations?

Yes, replays of the Tarsus investor conference webcasts will be available within 48 hours of the live events. According to Tarsus, these archived recordings will remain accessible on the company’s website for a limited time, allowing investors to watch after the scheduled sessions.

Where can I find more information about Tarsus (TARS) participation in the September 2026 investor conferences?

More information on Tarsus participation is available in the events section of the company’s website. According to Tarsus, this page will host live webcast links, event timing details, and replay access for both the Wells Fargo and H.C. Wainwright conferences.